NEW YORK (GenomeWeb) – Transplant Genomics has announced a collaboration with the Mayo Clinic to develop, validate, and commercialize diagnostic testing for solid organ transplant recipients.
Under the terms of the agreement the partners will perform a multi-year assessment of the firm’s TruGraf test for renal transplant monitoring at Mayo campuses in Minnesota, Arizona, and Florida. They will also co-develop new tests for other types of organ and will launch exploratory studies of heart and liver transplantation monitoring.
Comments